IDE196 is named as a drug or biological intervention in 2 clinical trials in our USA and UK trial registers, 1 of which is recruiting. The lead sponsor is IDEAYA Biosciences. Registered phases: Phase 2/3 and Phase 1/2. Conditions studied include Metastatic Uveal Melanoma; Cutaneous Melanoma; Colorectal Cancer.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT03947385 | Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions Metastatic Uveal Melanoma, Cutaneous Melanoma, Colorectal Cancer |
Phase 1/2 | Recruiting |
| NCT05987332 | IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma (ClinicalTrials.gov ↗) Metastatic Uveal Melanoma |
Phase 2/3 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Metastatic Uveal Melanoma | 2 |
| Cutaneous Melanoma | 1 |
| Colorectal Cancer | 1 |
| Other Solid Tumors | 1 |
| Lead sponsor | Trials |
|---|---|
| IDEAYA Biosciences | 2 |
| Register | IDE196 trials |
|---|---|
| Clinical trials in USA | 2 |
| Clinical trials in UK | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how IDE196 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists IDE196 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.